her-header

Vaginal Atrophy: Concerns on Low Dose Vaginal Estrogen

From the Show: HER
Summary: What is the most important information you should know about this labeling issue?
Air Date: 9/10/15
Duration: 10
Host: Michelle King Robson and Pam Peeke, MD
Guest Bio: Wulf H. Utian MD, PhD
Wulf H UtianWulf H. Utian MD, PhD, DSc, FRCOG, FACOG, FICS, is a physician reproductive endocrinologist, and world-renowned researcher, author, and lecturer on menopause and infertility.

An early pioneer of in vitro fertilization, he started the world's first menopause research center. Among numerous international awards, he was honored by Good Housekeeping as "one of America's best physicians in women's health," by Ladies Home Journal as one of the "top ten researchers in women's health," by the FDA with an FDA Citation "for the collective outstanding performance of the 'Menopause and Hormones Information Campaign,'" and most recently in Canada with the first SIGMA/Canadian Menopause Society "Menopause Trail Blazer Award."

He is Professor Emeritus of Reproductive Biology, Case Western Reserve University, Consultant in Women's Health at the Cleveland Clinic, and Chairman of the Advisory Board of Rapid Medical Research. Previously, he was Director of OB/GYN at University Hospitals of Cleveland.

He founded the International Menopause Society, and the North American Menopause Society. In 2015 he returned to NAMS as Interim Executive Director to assist in the reorganization of the Society, and transition of leadership. He was Medical Editor of Maturitas, Founding Editor of Menopause (1994-2010), and Editor of Menopause Management.

He has written over 230 scientific papers related to women's health, and has authored several books, the most recent including CHANGE YOUR MENOPAUSE – Why one size does not fit all, his successful self-help book THE UTIAN STRATEGY - Is this your problem or is this my problem? and FINDING THE UNEXPECTED – Tracing Utian Family Roots in Lithuania.
Vaginal Atrophy: Concerns on Low Dose Vaginal Estrogen
According to the Mayo Clinic, vaginal atrophy is the thinning, drying, and inflammation of the vaginal walls due to your body having less estrogen.

Vaginal atrophy typically occurs after menopause, but it can develop at any time if your estrogen levels decline.

What are some of the symptoms?

Some of the symptoms include vaginal burning and itching, vaginal discharge, urgency to urinate, light bleeding after intercourse, discomfort during intercourse, and genital itching.

One of the treatment options is low-dose vaginal estrogen. However, many researchers and doctors are urging modifications to the labeling of low-dose vaginal estrogen to further protect women who need to use it.

Why should the product labeling for low-dose vaginal estrogen be changed?

Wulf H. Utian MD, PhD, shares the symptoms of vaginal atrophy and if the product labeling should be changed on low-dose vaginal estrogen.
FREE RadioMD Newsletter: